106 related articles for article (PubMed ID: 2901430)
1. Medullary thyroid carcinoma: prognosis of familial versus sporadic disease and the role of radiotherapy.
Samaan NA; Schultz PN; Hickey RC
J Clin Endocrinol Metab; 1988 Oct; 67(4):801-5. PubMed ID: 2901430
[TBL] [Abstract][Full Text] [Related]
2. Medullary thyroid carcinoma: prognosis of familial versus nonfamilial disease and the role of radiotherapy.
Samaan NA; Schultz PN; Hickey RC
Horm Metab Res Suppl; 1989; 21():21-5. PubMed ID: 2807151
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of nondiploid DNA determined by flow cytometry in sporadic and familial medullary thyroid carcinoma.
Hay ID; Ryan JJ; Grant CS; Bergstralh EJ; van Heerden JA; Goellner JR
Surgery; 1990 Dec; 108(6):972-9; discussion 979-80. PubMed ID: 2247843
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in medullary thyroid carcinoma: evaluation of 741 patients from the German Medullary Thyroid Carcinoma Register.
Raue F; Kotzerke J; Reinwein D; Schröder S; Röher HD; Deckart H; Höfer R; Ritter M; Seif F; Buhr H
Clin Investig; 1993 Jan; 71(1):7-12. PubMed ID: 8095831
[TBL] [Abstract][Full Text] [Related]
5. [The prognostic importance of calcitonin screening in familial medullary thyroid carcinoma].
Raue F; Geiger S; Buhr H; Frank-Raue K; Ziegler R
Dtsch Med Wochenschr; 1993 Jan; 118(3):49-52. PubMed ID: 8425457
[TBL] [Abstract][Full Text] [Related]
6. Association of mitochondrial DNA transversion mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome.
Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
Oncogene; 2006 Feb; 25(5):677-84. PubMed ID: 16205644
[TBL] [Abstract][Full Text] [Related]
7. Prognostic variables and calcitonin in medullary thyroid cancer.
Clark JR; Fridman TR; Odell MJ; Brierley J; Walfish PG; Freeman JL
Laryngoscope; 2005 Aug; 115(8):1445-50. PubMed ID: 16094121
[TBL] [Abstract][Full Text] [Related]
8. Long term prognosis of medullary thyroid carcinoma in 39 patients.
Voutilainen PE; Multanen M; Haapiainen RK; Haglund CH; Sane T; Sivula AH
Ann Chir Gynaecol; 2000; 89(4):292-7. PubMed ID: 11204961
[TBL] [Abstract][Full Text] [Related]
9. Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients.
Saad MF; Ordonez NG; Rashid RK; Guido JJ; Hill CS; Hickey RC; Samaan NA
Medicine (Baltimore); 1984 Nov; 63(6):319-42. PubMed ID: 6503683
[TBL] [Abstract][Full Text] [Related]
10. [Medullary carcinoma of the thyroid gland and the APUD system].
Neradilová M
Cesk Pediatr; 1992 Aug; 47(8):492-6. PubMed ID: 1356639
[TBL] [Abstract][Full Text] [Related]
11. Long-term prognosis of medullary thyroid carcinoma.
Rendl G; Manzl M; Hitzl W; Sungler P; Pirich C
Clin Endocrinol (Oxf); 2008 Sep; 69(3):497-505. PubMed ID: 18331612
[TBL] [Abstract][Full Text] [Related]
12. Comparison of sporadic and hereditary forms of medullary thyroid carcinoma.
Rosenberg-Bourgin M; Gardet P; de Sahb R; Schlumberger M; Caillou B; Guilloud-Bataille M; Travagli JP; Feingold N; Parmentier C
Henry Ford Hosp Med J; 1989; 37(3-4):141-3. PubMed ID: 2576948
[TBL] [Abstract][Full Text] [Related]
13. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
14. Low incidence of loss of chromosome 10 in sporadic and hereditary human medullary thyroid carcinoma.
Nelkin BD; Nakamura Y; White RW; de Bustros AC; Herman J; Wells SA; Baylin SB
Cancer Res; 1989 Aug; 49(15):4114-9. PubMed ID: 2568166
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics in sporadic and familial medullary thyroid carcinoma. A nationwide study of 249 patients in Sweden from 1959 through 1981.
Bergholm U; Adami HO; Bergström R; Johansson H; Lundell G; Telenius-Berg M; Akerström G
Cancer; 1989 Mar; 63(6):1196-204. PubMed ID: 2563669
[TBL] [Abstract][Full Text] [Related]
16. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center.
Elisei R; Romei C; Cosci B; Agate L; Bottici V; Molinaro E; Sculli M; Miccoli P; Basolo F; Grasso L; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2007 Dec; 92(12):4725-9. PubMed ID: 17895320
[TBL] [Abstract][Full Text] [Related]
17. Medullary thyroid carcinoma experienced at Kanazawa University Hospital.
Mizukami Y; Nonomura A; Michigishi T; Noguchi M; Ohtake S; Nakamura S; Ishizaki T
J Surg Oncol; 1996 Jan; 61(1):27-33. PubMed ID: 8544456
[TBL] [Abstract][Full Text] [Related]
18. C-cell hyperplasia and medullary thyroid carcinoma: clinicopathological and genetic correlations in 66 consecutive patients.
Guyétant S; Josselin N; Savagner F; Rohmer V; Michalak S; Saint-André JP
Mod Pathol; 2003 Aug; 16(8):756-63. PubMed ID: 12920219
[TBL] [Abstract][Full Text] [Related]
19. Statistical analysis of histomorphological findings in medullary thyroid carcinoma: distinction between the different familial forms of the disease. G.E.T.C. Groupe d'Etude des Tumeurs a Calcitonine.
Franc B; Rosenberg-Bourgin M; Auvert B; Caillou B; Dutrieux-Berger N; Floquet J; Houcke-Lecomte M; Justrabo E; Labat-Moleur F; Le Bodic MF
Henry Ford Hosp Med J; 1992; 40(3-4):261-3. PubMed ID: 1362419
[TBL] [Abstract][Full Text] [Related]
20. [Multiple endocrine neoplasia type 2: familial variant of medullary carcinoma of the thyroid gland].
Neradilová M; Soutorová M; Vlcek P
Vnitr Lek; 1992 Sep; 38(9):850-9. PubMed ID: 1362306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
